Skip to content

Effect of repetitive transcranial magnetic stimulation combined with ketamine on perioperative anxiety and depression in patients with cancer:A multicenter, double-blind, randomized controlled study

Effect of repetitive transcranial magnetic stimulation combined with ketamine on perioperative anxiety and depression in patients with cancer:A multicenter, double-blind, randomized controlled study

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400088360
Enrollment
Unknown
Registered
2024-08-16
Start date
2024-09-01
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Perioperative anxiety and depression

Interventions

Repetitive transcranial magnetic stimulation combined with ketamine group:Repetitive transcranial magnetic stimulation combined with ketamine
Repetitive transcranial magnetic fake stimulation combined with ketamine group:Repetitive transcranial magnetic fake stimulation combined with ketamine

Sponsors

Jiaxing First Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: (1) patients undergoing elective tumor resection, (2) older than 18 years, (3) ASA classification ?-?, (4) had never taken an antidepressant or had not taken one for at least two weeks; (5) ability to cooperate with the completion of the trial programme and to correctly understand the contents of the assessments; (6) all subjects and their families gave informed consent and signed an informed consent form for the examination items performed

Exclusion criteria

Exclusion criteria: (1) preoperative diagnosis of mental, bipolar disorder or related disorders, (2) previous history of epilepsy or seizure onset, (3) craniocerebral or scalp injury, or other brain diseases, or a history of surgery, (4) metal implants (including artificial pacemaker, intraocular metal implants, history of intracranial metal implantation, cochlea, etc.) ;(5)pregnant women or women in the preconception period; (6) patients with a history of alcohol abuse or dependence in the last two months; and (7) patients with a history of allergy to any of the drugs used in the trial protocol

Design outcomes

Primary

MeasureTime frame
Indicators of anxiety and depression;Specific metabolic markers;

Secondary

MeasureTime frame
Incidence of sleep disorders;visual analogue scale;

Countries

China

Contacts

Public ContactHuadong Ni

Jiaxing First Hospital

huadongni@163.com+86 150 6838 6387

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026